Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025
   EV/Core EBITDA(x) 11.348.70

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.34
Mar20258.70

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.34
30.34
Mar2025 8.7 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹2,335.2 Cr -4.5% -2.1% 160.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹240,780.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,828.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,305.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,759.0 Cr 4.9% 7.7% -2.5% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-4.5%

-2.1%

160.6%

SENSEX

-1.5%

-1.2%

-11.8%


You may also like the below Video Courses